SUSMED,Inc. Cash Flow Statement

Financials in millions JPY. Fiscal year is July - June.

Millions JPY. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Net Income	-578	-356	-49	-233	-	-
Depreciation & Amortization	5	5	5	2	-	-
Loss (Gain) From Sale of Assets	5	2	5	15	-	-
Other Operating Activities	-	1	-	51	-	-
Change in Accounts Receivable	-9	-	-1	-3	-	-
Change in Accounts Payable	-30	-14	11	-15	-	-
Change in Other Net Operating Assets	81	132	129	18	-	-
Operating Cash Flow	-526	-230	100	-165	-	-
Capital Expenditures	-4	-3	-6	-12	-	-
Sale (Purchase) of Intangibles	-16	-6	-12	-	-	-
Other Investing Activities	1	1	-	-8	-	-
Investing Cash Flow	-19	-8	-18	-20	-	-
Issuance of Common Stock	22	37	61	3,481	-	-
Other Financing Activities	-	-	1	-18	-	-
Financing Cash Flow	22	37	62	3,463	-	-
Miscellaneous Cash Flow Adjustments	1	-	-	-1	-	-
Net Cash Flow	-522	-201	144	3,277	-	-
Free Cash Flow	-530	-233	94	-177	-	-
Free Cash Flow Margin	-353.33%	-68.13%	17.74%	-56.01%	-	-
Free Cash Flow Per Share	-31.64	-13.96	5.73	-12.05	-	-
Cash Income Tax Paid	1	1	1	-	-	-
Levered Free Cash Flow	-383	-150.13	88	-145.75	-	-
Unlevered Free Cash Flow	-383	-150.13	88	-145.75	-	-
Change in Net Working Capital	8	-82	-131	-8	-38	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.